JP6002148B2 - 経表面局所イソオキサゾリン製剤 - Google Patents

経表面局所イソオキサゾリン製剤 Download PDF

Info

Publication number
JP6002148B2
JP6002148B2 JP2013545416A JP2013545416A JP6002148B2 JP 6002148 B2 JP6002148 B2 JP 6002148B2 JP 2013545416 A JP2013545416 A JP 2013545416A JP 2013545416 A JP2013545416 A JP 2013545416A JP 6002148 B2 JP6002148 B2 JP 6002148B2
Authority
JP
Japan
Prior art keywords
compound
formulation
transsurface
administration
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2013545416A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014504586A (ja
JP2014504586A5 (OSRAM
Inventor
フツクス，シユテフアン
ヘツケロト，アンヤ・レジーナ
ミユーラー，ラモナ
ビリアムス，ヘイケ
ゾラー，ハルトムート
Original Assignee
インターベット インターナショナル ベー． フェー．
インターベット インターナショナル ベー． フェー．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43971048&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP6002148(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by インターベット インターナショナル ベー． フェー．, インターベット インターナショナル ベー． フェー． filed Critical インターベット インターナショナル ベー． フェー．
Publication of JP2014504586A publication Critical patent/JP2014504586A/ja
Publication of JP2014504586A5 publication Critical patent/JP2014504586A5/ja
Application granted granted Critical
Publication of JP6002148B2 publication Critical patent/JP6002148B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/80—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
JP2013545416A 2010-12-27 2011-12-22 経表面局所イソオキサゾリン製剤 Active JP6002148B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP10197089 2010-12-27
EP10197089.5 2010-12-27
US201161430240P 2011-01-06 2011-01-06
US61/430,240 2011-01-06
PCT/EP2011/073828 WO2012089622A2 (en) 2010-12-27 2011-12-22 Topical localized isoxazoline formulation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016139272A Division JP6246864B2 (ja) 2010-12-27 2016-07-14 経表面局所イソオキサゾリン製剤

Publications (3)

Publication Number Publication Date
JP2014504586A JP2014504586A (ja) 2014-02-24
JP2014504586A5 JP2014504586A5 (OSRAM) 2015-02-05
JP6002148B2 true JP6002148B2 (ja) 2016-10-05

Family

ID=43971048

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2013545416A Active JP6002148B2 (ja) 2010-12-27 2011-12-22 経表面局所イソオキサゾリン製剤
JP2016139272A Active JP6246864B2 (ja) 2010-12-27 2016-07-14 経表面局所イソオキサゾリン製剤
JP2017217049A Active JP6514754B2 (ja) 2010-12-27 2017-11-10 経表面局所イソオキサゾリン製剤

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2016139272A Active JP6246864B2 (ja) 2010-12-27 2016-07-14 経表面局所イソオキサゾリン製剤
JP2017217049A Active JP6514754B2 (ja) 2010-12-27 2017-11-10 経表面局所イソオキサゾリン製剤

Country Status (19)

Country Link
US (4) US9173870B2 (OSRAM)
EP (1) EP2658542B2 (OSRAM)
JP (3) JP6002148B2 (OSRAM)
KR (2) KR102027723B1 (OSRAM)
CN (2) CN103260621B (OSRAM)
AU (2) AU2016201954B2 (OSRAM)
BR (1) BR112013015503A2 (OSRAM)
CA (1) CA2822839C (OSRAM)
DK (1) DK2658542T4 (OSRAM)
ES (1) ES2908094T5 (OSRAM)
FI (1) FI2658542T4 (OSRAM)
HU (1) HUE058291T2 (OSRAM)
MX (2) MX356926B (OSRAM)
NZ (1) NZ611476A (OSRAM)
PL (1) PL2658542T5 (OSRAM)
PT (1) PT2658542T (OSRAM)
RU (2) RU2633061C2 (OSRAM)
WO (1) WO2012089622A2 (OSRAM)
ZA (1) ZA201304514B (OSRAM)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016216489A (ja) * 2010-12-27 2016-12-22 インターベット インターナショナル ベー． フェー． グリコフロールを含む経表面局所イソオキサゾリン製剤
JP2016222691A (ja) * 2010-12-27 2016-12-28 インターベット インターナショナル ベー． フェー． 経表面局所イソオキサゾリン製剤
KR102079347B1 (ko) * 2018-11-30 2020-02-19 문현규 치과용 유닛 체어

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2014CN02128A (OSRAM) 2011-09-12 2015-05-29 Merial Ltd
PT3216448T (pt) 2012-02-06 2019-07-08 Boehringer Ingelheim Animal Health Usa Inc Composições veterinárias orais parasiticidas que compreendem agentes, métodos e métodos ativos que agem sistemicamente
JO3626B1 (ar) 2012-02-23 2020-08-27 Merial Inc تركيبات موضعية تحتوي على فيبرونيل و بيرميثرين و طرق استخدامها
WO2013150052A1 (en) 2012-04-04 2013-10-10 Intervet International B.V. Soft chewable pharmaceutical products
PT3063144T (pt) 2013-11-01 2021-10-28 Boehringer Ingelheim Animal Health Usa Inc Compostos de isoxazolina antiparasitários e pesticidas
ES2950885T3 (es) 2013-12-20 2023-10-16 Intervet Int Bv Uso de compuestos de isoxazolina en aves de corral
PL3082867T3 (pl) 2013-12-20 2024-05-13 Intervet International B.V. Kompozycje izoksazoliny i ich zastosowanie w zapobieganiu lub leczeniu inwazji pasożytów u zwierząt
JP6682719B2 (ja) 2014-04-17 2020-04-15 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 寄生生物から動物を保護するためのマロノニトリル化合物の使用
WO2016022066A1 (en) 2014-08-04 2016-02-11 Jerry Tan Eye Surgery Pte Ltd Pharmaceutical compositions for demodex related blepharitis and eyelid crusting
RU2709198C2 (ru) 2014-12-22 2019-12-17 Интервет Интернэшнл Б.В. Применение изоксазолиновых соединений для лечения демодекоза
UY36570A (es) 2015-02-26 2016-10-31 Merial Inc Formulaciones inyectables de acción prolongada que comprenden un agente activo isoxazolina, métodos y usos de las mismas
DK3298027T3 (da) 2015-05-20 2021-08-09 Boehringer Ingelheim Animal Health Usa Inc Anthelmintiske depsipeptidforbindelser
US20170333305A1 (en) * 2016-05-23 2017-11-23 Microban Products Company Topical skin product having retention property
MX380497B (es) 2016-10-14 2025-03-11 Boehringer Ingelheim Animal Health Usa Inc Compuestos de vinil isoxazolina pesticidas y parasiticidas.
MX2019005628A (es) 2016-11-16 2019-12-18 Boehringer Ingelheim Animal Health Usa Inc Compuestos depsipeptidos antihelminticos.
MX2020001724A (es) 2017-08-14 2020-07-29 Boehringer Ingelheim Animal Health Usa Inc Compuestos de pirazol-isoxazolina plaguicidas y parasiticidas.
JP7274479B2 (ja) * 2017-11-23 2023-05-16 セバ・サンテ・アニマル 寄生虫の寄生を治療するためのモキシデクチンを含有する組成物
KR20200111177A (ko) 2017-12-15 2020-09-28 타르서스 파마수티칼스, 아이엔씨. 안검염을 치료하기 위한 이속사졸린 구충제 제제 및 방법
AR113997A1 (es) 2017-12-21 2020-07-08 Intervet Int Bv Composiciones antiparasitarias para unción dorsal continua
CA3106092A1 (en) 2018-07-09 2020-01-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anthelminthic heterocyclic compounds
US11773066B2 (en) 2018-11-20 2023-10-03 Boehringer Ingelheim Animal Health USA Inc. Indazolylcyanoethylamino compound, compositions of same, method of making, and methods of using thereof
CN119285648A (zh) 2019-03-19 2025-01-10 勃林格殷格翰动物保健有限公司 驱虫的氮杂-苯并噻吩和氮杂-苯并呋喃化合物
US12502377B2 (en) 2019-04-04 2025-12-23 Tarsus Pharmaceuticals, Inc. Method of eradicating ticks that attach to humans using lotilaner formulations
CA3138263A1 (en) * 2019-05-03 2020-11-12 Intervet International B.V. Injectable pharmaceutical compositions and uses thereof
MX2022007455A (es) 2019-12-18 2022-08-15 Elanco Tiergesundheit Ag Derivados de isoxazolina como plaguicidas.
FR3107531B1 (fr) * 2020-02-20 2022-02-25 Rl Innovation .composition liquide ou en gel, ecologique permettant l’enlevement des graffittis, chewing-gums, colles, resines sur tous supports poreux ou non ainsi que tous marquages routier
PH12022553222A1 (en) 2020-05-29 2024-02-12 Boehringer Ingelheim Animal Health Usa Inc Anthelmintic heterocyclic compounds
KR20230043904A (ko) 2020-07-24 2023-03-31 엘랑코 유에스 인코포레이티드 이속사졸린 화합물 및 이의 중간체의 제조 공정
CH717763A2 (de) 2020-08-18 2022-02-28 Swibox Ag Abzweigsystem für elektrische Leiter.
US20240116854A1 (en) 2021-01-27 2024-04-11 Intervet Inc. Cyclopropylamide compounds against parasites in fish
WO2022162016A1 (en) 2021-01-27 2022-08-04 Intervet International B.V. Cyclopropylamide compounds against parasites in fish
CN118715163A (zh) 2022-02-17 2024-09-27 勃林格殷格翰动物保健有限公司 用于提供流体制品邮寄封的方法和系统
NO20240925A1 (en) 2023-09-15 2025-03-17 Evah Atlantic Inc Dihydroisoxazole compound for use in reducing ectoparasite infestations on fish
WO2025191150A2 (en) 2024-03-15 2025-09-18 Krka, D.D., Novo Mesto Stable isoxazoline formulation for topical application to the skin

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3984564A (en) 1972-06-08 1976-10-05 Sankyo Company Limited Antibiotic substances B-41, their production and their use as insecticides and acaricides
US3950360A (en) 1972-06-08 1976-04-13 Sankyo Company Limited Antibiotic substances
JPS60218303A (ja) * 1984-04-13 1985-11-01 Mitsubishi Chem Ind Ltd 忌避剤組成物
US4916154A (en) 1986-09-12 1990-04-10 American Cyanamid Company 23-Imino derivatives of LL-F28249 compounds
IL98599A (en) 1990-06-28 1995-06-29 Merck & Co Inc Stable salts of 4"-deoxy-4"-epi-methylamino avermectin b1a/b1b and insecticidal compositions containing them
JPH04217606A (ja) * 1990-11-30 1992-08-07 Mitsubishi Gas Chem Co Inc 吸血害虫の吸血阻害剤
US5874479A (en) 1991-03-01 1999-02-23 Warner-Lambert Company Therapeutic permeation enhanced-wound healing compositions and methods for preparing and using same
US5399717A (en) 1993-09-29 1995-03-21 Merck & Co., Inc. Glycosidation route to 4"-epi-methylamino-4"-deoxyavermectin B1
US7906128B2 (en) * 2002-10-21 2011-03-15 Wyeth Llc Use of neuronal sodium channel antagonists for the control of ectoparasites in homeothermic animals
US8119150B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US20050147687A1 (en) * 2003-07-18 2005-07-07 Julia Rashba-Step Methods for fabrication, uses and compositions of small spherical particles of AAT prepared by controlled phase separation
US7422215B2 (en) 2003-10-08 2008-09-09 Seven Generations, Inc. Biased card deal
JP4883296B2 (ja) 2004-03-05 2012-02-22 日産化学工業株式会社 イソキサゾリン置換ベンズアミド化合物及び有害生物防除剤
CN100566566C (zh) * 2004-10-08 2009-12-09 惠氏公司 三亚螨（amitraz）组合物
TWI350728B (en) * 2004-10-08 2011-10-21 Wyeth Corp Amitraz compositions
US20060293260A1 (en) † 2005-05-24 2006-12-28 Wyeth Useful high load concentrate compositions for control of ecto-and endo-parasites
TWI368505B (en) 2005-05-24 2012-07-21 Wyeth Corp Versatile high load concentrate compositions for control of ecto-parasites
US7749527B2 (en) 2005-05-24 2010-07-06 Wyeth Llc Gel compositions for control of ecto-parasites
TWI412322B (zh) 2005-12-30 2013-10-21 Du Pont 控制無脊椎害蟲之異唑啉
EP2022776A4 (en) 2006-05-31 2009-10-21 Univ Hokkaido Nat Univ Corp FLUOROAMINES COMPRISING A PERFLUOROALKYL GROUP, PROCESS FOR PRODUCTION THEREOF, FLUOROAMINE FLUORINATION METHOD AND METHOD FOR RECOVERING AN AMIDE COMPRISING A PERFLUOROALKYL GROUP
TW200846029A (en) † 2007-02-09 2008-12-01 Wyeth Corp High dose, long-acting ectoparasiticide for extended control
CL2008001614A1 (es) 2007-06-05 2008-08-08 Wyeth Corp Composicion parasiticida veterinaria que comprende un disolvente que no contiene hidroxilo, un estabilizador, amitraz y opcionalmente una lactona macrociclica y miristato de isopropilo; y su uso para tratar o controlar una infestacion o infeccion par
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
MX2009013748A (es) 2007-06-27 2010-01-26 Du Pont Metodo de control de plagas en animales.
TWI556741B (zh) * 2007-08-17 2016-11-11 英特威特國際股份有限公司 異唑啉組成物及其作為抗寄生蟲藥上的應用
ES2442342T3 (es) 2008-12-18 2014-02-11 Novartis Ag Derivados de las isoxazolinas y su uso como pesticida
BRPI0923009B1 (pt) 2008-12-19 2018-07-17 Elanco Tiergesundheit Ag compostos de isoxazolina, composição para o controle de parasitas e uso de compostos de isoxazolina para o preparo de composição para o controle de parasitas
NZ594259A (en) 2009-02-23 2012-12-21 Wyeth Llc Improved-scent ectoparasiticidal formulation comprising metaflumizone and fructone
MX384937B (es) 2009-12-17 2025-03-14 Merial Ltd Compuestos de dihidroazol antiparasiticos y composiciones que comprenden los mismos.
CN101780020B (zh) * 2010-02-09 2011-12-28 广东名臣有限公司 一种清凉、止痒、驱蚊的花露水
EP2556060A1 (en) 2010-04-08 2013-02-13 Ah Usa 42 Llc Substituted 3,5- diphenyl-isoxazoline derivatives as insecticides and acaricides
ES2908094T5 (en) * 2010-12-27 2025-08-12 Intervet Int Bv Topical localized isoxazoline formulation
PL2658541T3 (pl) * 2010-12-27 2022-04-04 Intervet International B.V. Preparat izoksazoliny do stosowania miejscowego zawierający glikofurol
WO2018039508A1 (en) 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016216489A (ja) * 2010-12-27 2016-12-22 インターベット インターナショナル ベー． フェー． グリコフロールを含む経表面局所イソオキサゾリン製剤
JP2016222691A (ja) * 2010-12-27 2016-12-28 インターベット インターナショナル ベー． フェー． 経表面局所イソオキサゾリン製剤
JP2018048194A (ja) * 2010-12-27 2018-03-29 インターベット インターナショナル ベー． フェー． 経表面局所イソオキサゾリン製剤
KR102079347B1 (ko) * 2018-11-30 2020-02-19 문현규 치과용 유닛 체어

Also Published As

Publication number Publication date
US20180085352A1 (en) 2018-03-29
CA2822839A1 (en) 2012-07-05
ZA201304514B (en) 2014-03-26
WO2012089622A3 (en) 2012-11-15
RU2749733C2 (ru) 2021-06-16
DK2658542T3 (da) 2022-03-28
AU2016201954B2 (en) 2017-11-23
WO2012089622A2 (en) 2012-07-05
JP2014504586A (ja) 2014-02-24
RU2017118161A (ru) 2018-10-30
JP2018048194A (ja) 2018-03-29
JP6514754B2 (ja) 2019-05-15
US9532978B2 (en) 2017-01-03
EP2658542A2 (en) 2013-11-06
AU2017254818B2 (en) 2019-08-01
US20160015689A1 (en) 2016-01-21
NZ611476A (en) 2015-10-30
PL2658542T3 (pl) 2022-06-20
HUE058291T2 (hu) 2022-07-28
DK2658542T4 (da) 2025-08-25
EP2658542B2 (en) 2025-06-04
CN103260621A (zh) 2013-08-21
BR112013015503A2 (pt) 2017-06-27
AU2017254818A1 (en) 2017-11-16
EP2658542B1 (en) 2022-01-26
RU2017118161A3 (OSRAM) 2020-07-30
CN103260621B (zh) 2016-08-24
AU2011351578A1 (en) 2013-06-20
MX383895B (es) 2025-03-14
CN105616406A (zh) 2016-06-01
JP6246864B2 (ja) 2017-12-13
JP2016222691A (ja) 2016-12-28
CA2822839C (en) 2020-12-29
US10864195B2 (en) 2020-12-15
ES2908094T5 (en) 2025-08-12
RU2633061C2 (ru) 2017-10-11
RU2013135280A (ru) 2015-02-10
KR20130130761A (ko) 2013-12-02
FI2658542T4 (fi) 2025-09-02
MX356926B (es) 2018-06-19
US9173870B2 (en) 2015-11-03
MX2013007500A (es) 2013-08-01
CN105616406B (zh) 2019-12-13
PL2658542T5 (pl) 2025-07-28
KR102027723B1 (ko) 2019-10-01
AU2016201954A1 (en) 2016-04-21
US20170071914A1 (en) 2017-03-16
ES2908094T3 (es) 2022-04-27
US20130281501A1 (en) 2013-10-24
KR20180125037A (ko) 2018-11-21
PT2658542T (pt) 2022-03-10

Similar Documents

Publication Publication Date Title
JP6246864B2 (ja) 経表面局所イソオキサゾリン製剤
JP6357508B2 (ja) グリコフロールを含む経表面局所イソオキサゾリン製剤
KR102193090B1 (ko) 국소 적용 이속사졸린 제제
AU2011351578B2 (en) Topical localized isoxazoline formulation

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141212

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20141212

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20151013

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160112

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20160315

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160714

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20160722

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20160809

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160902

R150 Certificate of patent or registration of utility model

Ref document number: 6002148

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R153 Grant of patent term extension

Free format text: JAPANESE INTERMEDIATE CODE: R153

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R153 Grant of patent term extension

Free format text: JAPANESE INTERMEDIATE CODE: R153

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250